Time of peritoneal cavity exposure influences postoperative glucose production

Can J Anaesth. 1999 Apr;46(4):352-8. doi: 10.1007/BF03013227.

Abstract

Purpose: To examine the effect of the duration of peritoneal cavity exposure on glucose metabolism after abdominal surgery.

Methods: In eight otherwise healthy patients (ASA 1) with uterine myoma, endogenous glucose production (Ra glucose) was measured immediately before and two hours after abdominal hysterectomy by a stable isotope dilution technique using primed continuous infusions of [6,6-2H2]-glucose. Plasma concentrations of glucose, lactate, insulin, glucagon, cortisol, epinephrine and norepinephrine were determined before, during (5 and 60 min after peritoneal incision, skin closure) and two hours after surgery. Pre- and postoperative glucose clearance was calculated as Ra glucose divided by plasma glucose concentration.

Results: Ra glucose increased from 11.8 +/- 1.2 to 16.8 +/- 3.2 micromol x kg(-1) x min(-1) two hours after hysterectomy (P < 0.05) with a correlation between the degree of increase and the time of peritoneal cavity exposure (r = 0.859, P = 0.006). Plasma glucose concentration increased after surgery from 4.7 +/- 0.8 to 8.3 +/- 1.9 mmol x l(-1) (P < 0.05), while glucose clearance decreased from 2.6 +/- 0.4 to 2.1 +/- 0.4 ml x kg(-1) x min(-1) (P < 0.05). Plasma concentrations of cortisol and catecholamines increased after hysterectomy (cortisol from 6 +/- 2 to 31 +/- 7 microg x dl(-1), epinephrine from 25 +/- 14 to 205 +/- 132 pg x ml(-1), norepinephrine from 182 +/- 82 to 377 +/- 132 pg x ml(-1), P < 0.05), whereas plasma lactate, insulin and glucagon concentrations remained unchanged.

Conclusion: The magnitude of increase of glucose production after abdominal hysterectomy is associated with the duration of peritoneal cavity exposure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Blood Glucose / analysis
  • Chromatography, High Pressure Liquid
  • Deuterium
  • Epinephrine / blood
  • Female
  • Follow-Up Studies
  • Gas Chromatography-Mass Spectrometry
  • Glucagon / blood
  • Glucose / administration & dosage
  • Glucose / metabolism*
  • Humans
  • Hydrocortisone / blood
  • Hysterectomy*
  • Indicator Dilution Techniques
  • Infusions, Intravenous
  • Insulin / blood
  • Lactates / blood
  • Leiomyoma / surgery
  • Linear Models
  • Norepinephrine / blood
  • Peritoneal Cavity / surgery*
  • Radioimmunoassay
  • Time Factors
  • Uterine Neoplasms / surgery

Substances

  • Blood Glucose
  • Insulin
  • Lactates
  • Glucagon
  • Deuterium
  • Glucose
  • Hydrocortisone
  • Norepinephrine
  • Epinephrine